Bilateral progressive orbital myositis as immune-related adverse event of pembrolizumab.

Autor: Nakajima I; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: jm-i-nakajima@kochi-u.ac.jp., Nakaizumi T; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan., Tsuji H; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
Jazyk: angličtina
Zdroj: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Aug; Vol. 59 (4), pp. e388. Date of Electronic Publication: 2024 Mar 08.
DOI: 10.1016/j.jcjo.2024.02.007
Databáze: MEDLINE
Externí odkaz: